The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation end products restricting intramolecular movement
Open Access
- 1 January 2009
- journal article
- research article
- Published by Walter de Gruyter GmbH in Cellular & Molecular Biology Letters
- Vol. 14 (4) , 575-586
Abstract
Human serum albumin (HSA) inhibits endothelial apoptosis in a highly specific manner. CNBr fragmentation greatly increases the effectiveness of this activity, suggesting that this type of protection is mediated by a partially cryptic albumin domain which is transiently exposed by intramolecular movement. Advanced glycation end-product (AGE) formation in HSA greatly reduces its intra-molecular movement. This study aimed to determine if this inhibits the anti-apoptotic activity of HSA, and if such inactivation could be reversed by CNBr fragmentation. HSA-AGE was prepared by incubating HSA with glucose, and assessed using the fructosamine assay, mass spectrometry, SDS-PAGE and fluorometry. Low levels of AGE in the HSA had little effect upon its anti-apoptotic activity, but when the levels of AGE were high and the intra-molecular movement was reduced, endothelial cell survival was also found to be reduced to levels equivalent to those in cultures without HSA or serum (p > 0.001). Survival was restored by the inclusion of native HSA, despite the presence of HSA with high levels of AGE. Also, CNBr fragmentation of otherwise inactive HSA-AGE restored the anti-apoptotic activity for endothelium. Apoptosis was confirmed by DNA gel electrophoresis, transmission electron microscopy and fluorescence-activated cell sorting analysis, and there was no evidence for direct toxicity in the HSA-AGE preparations. The results are consistent with the proposed role of intra-molecular movement in exposing the anti-apoptotic domain in HSA for endothelium. The levels of AGE formation required to inhibit the anti-apoptotic activity of HSA exceeded those reported for diabetes. Nonetheless, the data from this study seems to be the first example of reduced protein function due to AGE-restricted intra-molecular movement.Keywords
This publication has 34 references indexed in Scilit:
- The Anti-Apoptotic Activity of Albumin for Endothelium Is Mediated by a Partially Cryptic Protein Domain and Reduced by Inhibitors of G-Coupled Protein and PI-3 Kinase, but Is Independent of Radical Scavenging or Bound LipidJournal of Vascular Research, 2007
- Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell typesThe FEBS Journal, 2006
- Ultrastructural Changes in Endothelium during Apoptosis Indicate Low Microembolic PotentialJournal of Vascular Research, 2005
- Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditionsLife Sciences, 2005
- Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis – interrelation with traditional cardiovascular risk factorsThrombosis and Haemostasis, 2004
- Fluorometric and Mass Spectrometric Analysis of Nonenzymatic Glycosylated AlbuminBiochemical and Biophysical Research Communications, 2001
- Breaking the curse of the AGEsNature, 1996
- Role of Glycation in AgingAnnals of the New York Academy of Sciences, 1992
- Features of apoptotic cells measured by flow cytometryCytometry, 1992
- Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cellsBiochemical and Biophysical Research Communications, 1990